Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal Model

Background and Objectives: Cancer is one of the leading causes of death around the world with a very high degree of mortality. Conventional therapies by cytotoxic drugs have high levels of side-effects for patient. Chitosan is a biocompatible and biodegradable compound. Thus, according to the minimu...

Full description

Bibliographic Details
Main Authors: Neda Soleimani, Ashraf Mohabati Mobarez
Format: Article
Language:fas
Published: Qom University of Medical Sciences 2017-04-01
Series:Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
Subjects:
Online Access:http://journal.muq.ac.ir/browse.php?a_code=A-10-154-1&slc_lang=en&sid=1
_version_ 1831669360292265984
author Neda Soleimani
Ashraf Mohabati Mobarez
author_facet Neda Soleimani
Ashraf Mohabati Mobarez
author_sort Neda Soleimani
collection DOAJ
description Background and Objectives: Cancer is one of the leading causes of death around the world with a very high degree of mortality. Conventional therapies by cytotoxic drugs have high levels of side-effects for patient. Chitosan is a biocompatible and biodegradable compound. Thus, according to the minimum systemic toxicity for peptide and drug delivery, it is considered in applied programs. In this study, the Immunological effect of chitosan nanoparticles, was investigated on breast cancer cells in animal model. Methods: In this experimental model, chitosan nanoparticles were synthesized. The size and electrical charge were determined using DLS apparatus and SEM. After creation of tumor model in female BALB/c mice. Injections in the test and control groups, were performed intraperitoneally. IL-4 and IFN-&gamma; were assayed using ELISA method to investigate the immunomodulatory effects of the nanoparticles. Results: Electric charge and size of the nanoparticles were determined and confirmed to be +11 mv and 200 nm, respectively. The nanoparticle-treated group produced large amounts of IFN-&gamma; (213 pg/ml), while IL-4 level decreased (p<0.5). Conclusion: These nanoparticles has the potential to shift immune responses from a Th2 to Th1 through IFN-&gamma; production. Hence, these nanoparticles may be an appropriate and effective candidate for cancer therapy.
first_indexed 2024-12-19T22:57:58Z
format Article
id doaj.art-73e3f3639f4f48f18efd8406e64aff2c
institution Directory Open Access Journal
issn 1735-7799
2008-1375
language fas
last_indexed 2024-12-19T22:57:58Z
publishDate 2017-04-01
publisher Qom University of Medical Sciences
record_format Article
series Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
spelling doaj.art-73e3f3639f4f48f18efd8406e64aff2c2022-12-21T20:02:36ZfasQom University of Medical SciencesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum1735-77992008-13752017-04-0111219Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal ModelNeda Soleimani0Ashraf Mohabati Mobarez1 Shahid Beheshti University Tarbiat Modares University Background and Objectives: Cancer is one of the leading causes of death around the world with a very high degree of mortality. Conventional therapies by cytotoxic drugs have high levels of side-effects for patient. Chitosan is a biocompatible and biodegradable compound. Thus, according to the minimum systemic toxicity for peptide and drug delivery, it is considered in applied programs. In this study, the Immunological effect of chitosan nanoparticles, was investigated on breast cancer cells in animal model. Methods: In this experimental model, chitosan nanoparticles were synthesized. The size and electrical charge were determined using DLS apparatus and SEM. After creation of tumor model in female BALB/c mice. Injections in the test and control groups, were performed intraperitoneally. IL-4 and IFN-&gamma; were assayed using ELISA method to investigate the immunomodulatory effects of the nanoparticles. Results: Electric charge and size of the nanoparticles were determined and confirmed to be +11 mv and 200 nm, respectively. The nanoparticle-treated group produced large amounts of IFN-&gamma; (213 pg/ml), while IL-4 level decreased (p<0.5). Conclusion: These nanoparticles has the potential to shift immune responses from a Th2 to Th1 through IFN-&gamma; production. Hence, these nanoparticles may be an appropriate and effective candidate for cancer therapy.http://journal.muq.ac.ir/browse.php?a_code=A-10-154-1&slc_lang=en&sid=1neoplasms nanoparticles immune system
spellingShingle Neda Soleimani
Ashraf Mohabati Mobarez
Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal Model
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
neoplasms
nanoparticles
immune system
title Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal Model
title_full Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal Model
title_fullStr Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal Model
title_full_unstemmed Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal Model
title_short Immunological Effects of Chitosan Nanoparticles on Breast Cancer Cells in Animal Model
title_sort immunological effects of chitosan nanoparticles on breast cancer cells in animal model
topic neoplasms
nanoparticles
immune system
url http://journal.muq.ac.ir/browse.php?a_code=A-10-154-1&slc_lang=en&sid=1
work_keys_str_mv AT nedasoleimani immunologicaleffectsofchitosannanoparticlesonbreastcancercellsinanimalmodel
AT ashrafmohabatimobarez immunologicaleffectsofchitosannanoparticlesonbreastcancercellsinanimalmodel